Open Payments Annual Report to Congress Shows Fourth Straight Year of $8 Billion Plus in Payments Read more
OMB Memo Outlines All FDA Guidance’s Will Be Reviewed by the White House Prior to Publication Read more
Nevada Releases Diabetes Drug Transparency Report and Passes SB262 Adding Asthma Drugs to the Report Read more
Supreme Court Sends Merck’s Fosamax Product Liability Case Back to Appeals Court. Clear Evidence Company Submitted a Label Change to the FDA Read more
HHS-OIG Quarterly Report on Medicare Part B Identifies 10 Drugs for Potential Price Substitution Read more